Biochemical basis of anti-cancer-effects of phloretin—a natural dihydrochalcone

Molecules

Volumn 24, Issue 2, 2019, Pages

  Choi, Bu Young ^a  

^a Seowon University   (South Korea)

Author keywords

Apoptosis; Cell proliferation; Glucose uptake; Inflammation; Migration; Phloretin

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CHALCONE DERIVATIVE; DIHYDROCHALCONE; PHLORETIN;

ANIMAL; ANIMAL MODEL; CHEMISTRY; HUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CHALCONES; HUMANS; MODELS, ANIMAL; PHLORETIN;

EID: 85059989899     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules24020278     Document Type: Review

References (78)

1. Mann, J.R.; Backlund, M.G.; DuBois, R.N. Mechanisms of disease: Inflammatory mediators and cancer prevention. Nat. Clin. Pract. Oncol. 2005, 2, 202–210. [CrossRef] [PubMed]
2. Baer-Dubowska, W. Cancer chemopreventive agents-drugs for the 21st century? Acta Pol. Pharm. 2006, 63, 369–373. [PubMed]
3. Sporn, M.B. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 1976, 36, 2699–2702. [PubMed]
4. Moolgavkar, S.H. The multistage theory of carcinogenesis and the age distribution of cancer in man. J. Natl. Cancer Inst. 1978, 61, 49–52. [CrossRef] [PubMed]
5. Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3, 768–780. [CrossRef]
6. Tsuda, H.; Ohshima, Y.; Nomoto, H.; Fujita, K.; Matsuda, E.; Iigo, M.; Takasuka, N.; Moore, M.A. Cancer prevention by natural compounds. Drug Metab. Pharmacokinet. 2004, 19, 245–263. [CrossRef] [PubMed]
7. De Flora, S.; Ferguson, L.R. Overview of mechanisms of cancer chemopreventive agents. Mutat. Res. 2005, 591, 8–15. [CrossRef]
8. Kundu, J.K.; Surh, Y.J. Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals. Mutat. Res. 2005, 591, 123–146. [CrossRef]
9. Gerhauser, C. Cancer chemopreventive potential of apples, apple juice, and apple components. Planta Med. 2008, 74, 1608–1624. [CrossRef]
10. Zessner, H.; Pan, L.; Will, F.; Klimo, K.; Knauft, J.; Niewohner, R.; Hummer, W.; Owen, R.; Richling, E.; Frank, N.; et al. Fractionation of polyphenol-enriched apple juice extracts to identify constituents with cancer chemopreventive potential. Mol. Nutr. Food Res. 2008, 52, S28–S44. [CrossRef]
11. Fini, L.; Piazzi, G.; Daoud, Y.; Selgrad, M.; Maegawa, S.; Garcia, M.; Fogliano, V.; Romano, M.; Graziani, G.; Vitaglione, P.; et al. Chemoprevention of intestinal polyps in ApcMin/+ mice fed with western or balanced diets by drinking annurca apple polyphenol extract. Cancer Prev. Res. 2011, 4, 907–915. [CrossRef] [PubMed]
12. Nakamura, Y.; Watanabe, S.; Miyake, N.; Kohno, H.; Osawa, T. Dihydrochalcones: Evaluation as novel radical scavenging antioxidants. J. Agric. Food Chem 2003, 51, 3309–3312. [CrossRef] [PubMed]
13. Tanaka, K.; Ono, T.; Umeda, M. Inhibition of biological actions of 12-O-tetradecanoylphorbol-13-acetate by inhibitors of protein kinase C. Jpn. J. Cancer Res. 1986, 77, 1107–1113. [PubMed]
14. Park, S.Y.; Kim, E.J.; Shin, H.K.; Kwon, D.Y.; Kim, M.S.; Surh, Y.J.; Park, J.H. Induction of apoptosis in HT-29 colon cancer cells by phloretin. J. Med. Food 2007, 10, 581–586. [CrossRef] [PubMed]
15. Yang, K.C.; Tsai, C.Y.; Wang, Y.J.; Wei, P.L.; Lee, C.H.; Chen, J.H.; Wu, C.H.; Ho, Y.S. Apple polyphenol phloretin potentiates the anti-cancer actions of paclitaxel through induction of apoptosis in human hep G2 cells. Mol. Carcinog. 2009, 48, 420–431. [CrossRef] [PubMed]
16. Chang, W.T.; Huang, W.C.; Liou, C.J. Evaluation of the anti-inflammatory effects of phloretin and phlorizin in lipopolysaccharide-stimulated mouse macrophages. Food Chem. 2012, 134, 972–979. [CrossRef] [PubMed]
17. Wu, C.H.; Ho, Y.S.; Tsai, C.Y.; Wang, Y.J.; Tseng, H.; Wei, P.L.; Lee, C.H.; Liu, R.S.; Lin, S.Y. In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter. Int. J. Cancer 2009, 124, 2210–2219. [CrossRef]
18. Min, J.; Huang, K.; Tang, H.; Ding, X.; Qi, C.; Qin, X.; Xu, Z. Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1/2 and p38 MAPK pathways. Oncol. Rep. 2015, 34, 2871–2879. [CrossRef]
19. Shin, J.W.; Kundu, J.K.; Surh, Y.J. Phloretin inhibits phorbol ester-induced tumor promotion and expression of cyclooxygenase-2 in mouse skin: Extracellular signal-regulated kinase and nuclear factor-kappaB as potential targets. J. Med. Food 2012, 15, 253–257. [CrossRef]
20. Anand, M.A.; Suresh, K. Biochemical profiling and chemopreventive activity of phloretin on 7,12-Dimethylbenz (a) anthracene induced oral carcinogenesis in male golden Syrian hamsters. Toxicol. Int. 2014, 21, 179–185.
21. Oresajo, C.; Stephens, T.; Hino, P.D.; Law, R.M.; Yatskayer, M.; Foltis, P.; Pillai, S.; Pinnell, S.R. Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin. J. Cosmet. Dermatol. 2008, 7, 290–297. [CrossRef] [PubMed]
22. Kundu, J.K.; Surh, Y.J. Emerging avenues linking inflammation and cancer. Free Radic. Biol. Med. 2012, 52, 2013–2037. [CrossRef] [PubMed]
23. Eaden, J.; Abrams, K.; Ekbom, A.; Jackson, E.; Mayberry, J. Colorectal cancer prevention in ulcerative colitis: A case-control study. Aliment. Pharmacol. Ther. 2000, 14, 145–153. [CrossRef] [PubMed]
24. Lee, J.H.; Regmi, S.C.; Kim, J.A.; Cho, M.H.; Yun, H.; Lee, C.S.; Lee, J. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect. Immun. 2011, 79, 4819–4827. [CrossRef] [PubMed]
25. Lin, S.T.; Tu, S.H.; Yang, P.S.; Hsu, S.P.; Lee, W.H.; Ho, C.T.; Wu, C.H.; Lai, Y.H.; Chen, M.Y.; Chen, L.C. Apple Polyphenol Phloretin Inhibits Colorectal Cancer Cell Growth via Inhibition of the Type 2 Glucose Transporter and Activation of p53-Mediated Signaling. J. Agric. Food Chem. 2016, 64, 6826–6837. [CrossRef] [PubMed]
26. Huang, W.C.; Fang, L.W.; Liou, C.J. Phloretin Attenuates Allergic Airway Inflammation and Oxidative Stress in Asthmatic Mice. Front. Immunol. 2017, 8, 134. [CrossRef]
27. Wang, H.; Yang, T.; Wang, T.; Hao, N.; Shen, Y.; Wu, Y.; Yuan, Z.; Chen, L.; Wen, F. Phloretin attenuates mucus hypersecretion and airway inflammation induced by cigarette smoke. Int. Immunopharmacol. 2018, 55, 112–119. [CrossRef]
28. Wu, K.H.; Ho, C.T.; Chen, Z.F.; Chen, L.C.; Whang-Peng, J.; Lin, T.N.; Ho, Y.S. The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter. J. Food Drug Anal. 2018, 26, 221–231. [CrossRef]
29. Rezk, B.M.; Haenen, G.R.; van der Vijgh, W.J.; Bast, A. The antioxidant activity of phloretin: The disclosure of a new antioxidant pharmacophore in flavonoids. Biochem. Biophys. Res. Commun. 2002, 295, 9–13. [CrossRef]
30. Mendes, R.A.; BLS, E.S.; Takeara, R.; Freitas, R.G.; Brown, A.; de Souza, G.L.C. Probing the antioxidant potential of phloretin and phlorizin through a computational investigation. J. Mol. Model. 2018, 24, 101. [CrossRef]
31. Schaefer, S.; Baum, M.; Eisenbrand, G.; Dietrich, H.; Will, F.; Janzowski, C. Polyphenolic apple juice extracts and their major constituents reduce oxidative damage in human colon cell lines. Mol. Nutr. Food Res. 2006, 50, 24–33. [CrossRef] [PubMed]
32. Yang, Y.C.; Lii, C.K.; Lin, A.H.; Yeh, Y.W.; Yao, H.T.; Li, C.C.; Liu, K.L.; Chen, H.W. Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress. Free Radic. Biol. Med. 2011, 51, 2073–2081. [CrossRef] [PubMed]
33. Kim, J.; Durai, P.; Jeon, D.; Jung, I.D.; Lee, S.J.; Park, Y.M.; Kim, Y. Phloretin as a Potent Natural TLR2/1 Inhibitor Suppresses TLR2-Induced Inflammation. Nutrients 2018, 10, 868. [CrossRef] [PubMed]
34. Huang, W.C.; Lai, C.L.; Liang, Y.T.; Hung, H.C.; Liu, H.C.; Liou, C.J. Phloretin attenuates LPS-induced acute lung injury in mice via modulation of the NF-kappaB and MAPK pathways. Int. Immunopharmacol. 2016, 40, 98–105. [CrossRef] [PubMed]
35. Huang, W.C.; Wu, S.J.; Tu, R.S.; Lai, Y.R.; Liou, C.J. Phloretin inhibits interleukin-1beta-induced COX-2 and ICAM-1 expression through inhibition of MAPK, Akt, and NF-kappaB signaling in human lung epithelial cells. Food Funct. 2015, 6, 1960–1967. [CrossRef] [PubMed]
36. Huang, W.C.; Dai, Y.W.; Peng, H.L.; Kang, C.W.; Kuo, C.Y.; Liou, C.J. Phloretin ameliorates chemokines and ICAM-1 expression via blocking of the NF-kappaB pathway in the TNF-alpha-induced HaCaT human keratinocytes. Int. Immunopharmacol. 2015, 27, 32–37. [CrossRef]
37. Sekhon-Loodu, S.; Ziaullah; Rupasinghe, H.P. Docosahexaenoic acid ester of phloridzin inhibit lipopolysaccharide-induced inflammation in THP-1 differentiated macrophages. Int. Immunopharmacol. 2015, 25, 199–206. [CrossRef]
38. Chung, M.J.; Sohng, J.K.; Choi, D.J.; Park, Y.I. Inhibitory effect of phloretin and biochanin A on IgE-mediated allergic responses in rat basophilic leukemia RBL-2H3 cells. Life Sci. 2013, 93, 401–408. [CrossRef]
39. Xu, M.; Gu, W.; Shen, Z.; Wang, F. Anti-cancer Activity of Phloretin Against Human Gastric Cancer Cell Lines Involves Apoptosis, Cell Cycle Arrest, and Inhibition of Cell Invasion and JNK Signalling Pathway. Med. Sci. Monit. 2018, 24, 6551–6558. [CrossRef]
40. Duan, H.; Wang, R.; Yan, X.; Liu, H.; Zhang, Y.; Mu, D.; Han, J.; Li, X. Phloretin induces apoptosis of human esophageal cancer via a mitochondria-dependent pathway. Oncol. Lett. 2017, 14, 6763–6768. [CrossRef]
41. Ma, L.; Wang, R.; Nan, Y.; Li, W.; Wang, Q.; Jin, F. Phloretin exhibits an anti-cancer effect and enhances the anti-cancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases. Int. J. Oncol. 2016, 48, 843–853. [CrossRef] [PubMed]
42. Abkin, S.V.; Ostroumova, O.S.; Komarova, E.Y.; Meshalkina, D.A.; Shevtsov, M.A.; Margulis, B.A.; Guzhova, I.V. Phloretin increases the anti-tumor efficacy of intratumorally delivered heat-shock protein 70 kDa (HSP70) in a murine model of melanoma. Cancer Immunol. Immunother. 2016, 65, 83–92. [CrossRef] [PubMed]
43. Qin, X.; Xing, Y.F.; Zhou, Z.; Yao, Y. Dihydrochalcone Compounds Isolated from Crabapple Leaves Showed Anti-cancer Effects on Human Cancer Cell Lines. Molecules 2015, 20, 21193–21203. [CrossRef] [PubMed]
44. Oshima, H.; Oshima, M.; Inaba, K.; Taketo, M.M. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J. 2004, 23, 1669–1678. [CrossRef] [PubMed]
45. Muller-Decker, K.; Neufang, G.; Berger, I.; Neumann, M.; Marks, F.; Furstenberger, G. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc. Natl. Acad. Sci. USA 2002, 99, 12483–12488. [CrossRef] [PubMed]
46. Oshima, M.; Dinchuk, J.E.; Kargman, S.L.; Oshima, H.; Hancock, B.; Kwong, E.; Trzaskos, J.M.; Evans, J.F.; Taketo, M.M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87, 803–809. [CrossRef]
47. Tiano, H.F.; Loftin, C.D.; Akunda, J.; Lee, C.A.; Spalding, J.; Sessoms, A.; Dunson, D.B.; Rogan, E.G.; Morham, S.G.; Smart, R.C.; et al. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 2002, 62, 3395–3401.
48. Tanaka, T.; Kohno, H.; Suzuki, R.; Hata, K.; Sugie, S.; Niho, N.; Sakano, K.; Takahashi, M.; Wakabayashi, K. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int. J. Cancer 2006, 118, 25–34. [CrossRef]
49. Chun, K.S.; Cha, H.H.; Shin, J.W.; Na, H.K.; Park, K.K.; Chung, W.Y.; Surh, Y.J. Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappaB. Carcinogenesis 2004, 25, 445–454. [CrossRef]
50. Surh, Y.J.; Kundu, J.K.; Na, H.K.; Lee, J.S. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J. Nutr. 2005, 135, 2993S–3001S. [CrossRef]
51. Jung, M.; Triebel, S.; Anke, T.; Richling, E.; Erkel, G. Influence of apple polyphenols on inflammatory gene expression. Mol. Nutr. Food Res. 2009, 53, 1263–1280. [CrossRef] [PubMed]
52. Alsanea, S.; Gao, M.; Liu, D. Phloretin Prevents High-Fat Diet-Induced Obesity and Improves Metabolic Homeostasis. AAPS J. 2017, 19, 797–805. [CrossRef] [PubMed]
53. Kim, M.S.; Park, S.H.; Han, S.Y.; Kim, Y.H.; Lee, E.J.; Yoon Park, J.H.; Kang, Y.H. Phloretin suppresses thrombin-mediated leukocyte-platelet-endothelial interactions. Mol. Nutr. Food Res. 2014, 58, 698–708. [CrossRef] [PubMed]
54. Gao, S.S.; Chen, X.Y.; Zhu, R.Z.; Choi, B.M.; Kim, S.J.; Kim, B.R. Dual effects of phloretin on aflatoxin B1 metabolism: Activation and detoxification of aflatoxin B1. Biofactors 2012, 38, 34–43. [CrossRef] [PubMed]
55. Kim, M.S.; Kwon, J.Y.; Kang, N.J.; Lee, K.W.; Lee, H.J. Phloretin induces apoptosis in H-Ras MCF10A human breast tumor cells through the activation of p53 via JNK and p38 mitogen-activated protein kinase signaling. Ann. N. Y. Acad. Sci. 2009, 1171, 479–483. [CrossRef] [PubMed]
56. Kobori, M.; Shinmoto, H.; Tsushida, T.; Shinohara, K. Phloretin-induced apoptosis in B16 melanoma 4A5 cells by inhibition of glucose transmembrane transport. Cancer Lett. 1997, 119, 207–212. [CrossRef]
57. Kobori, M.; Iwashita, K.; Shinmoto, H.; Tsushida, T. Phloretin-induced apoptosis in B16 melanoma 4A5 cells and HL60 human leukemia cells. Biosci. Biotechnol. Biochem. 1999, 63, 719–725. [CrossRef] [PubMed]
58. Szliszka, E.; Czuba, Z.P.; Mazur, B.; Paradysz, A.; Krol, W. Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules 2010, 15, 5336–5353. [CrossRef] [PubMed]
59. Liu, Y.; Fan, C.; Pu, L.; Wei, C.; Jin, H.; Teng, Y.; Zhao, M.; Yu, A.C.; Jiang, F.; Shu, J.; et al. Phloretin induces cell cycle arrest and apoptosis of human glioblastoma cells through the generation of reactive oxygen species. J. Neurooncol. 2016, 128, 217–223. [CrossRef] [PubMed]
60. Yin, M.; Ma, W.; An, L. Cortactin in cancer cell migration and invasion. Oncotarget 2017, 8, 88232–88243. [CrossRef] [PubMed]
61. Zhang, Z.; Zou, Y.; Liang, M.; Chen, Y.; Luo, Y.; Yang, B.; Liu, F.; Qin, Y.; He, D.; Wang, F.; et al. Suppressor of fused (Sufu) promotes epithelial-mesenchymal transition (EMT) in cervical squamous cell carcinoma. Oncotarget 2017, 8, 114226–114238. [CrossRef] [PubMed]
62. Cho, S.H.; Park, Y.S.; Kim, H.J.; Kim, C.H.; Lim, S.W.; Huh, J.W.; Lee, J.H.; Kim, H.R. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Int. J. Oncol. 2012, 41, 211–218. [PubMed]
63. Cao, X.; Fang, L.; Gibbs, S.; Huang, Y.; Dai, Z.; Wen, P.; Zheng, X.; Sadee, W.; Sun, D. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother. Pharmacol. 2007, 59, 495–505. [CrossRef] [PubMed]
64. Nelson, J.A.; Falk, R.E. The efficacy of phloridzin and phloretin on tumor cell growth. Anti-Cancer Res. 1993, 13, 2287–2292.
65. Eno, J. Immunotherapy Through the Years. J. Adv. Pract. Oncol. 2017, 8, 747–753. [PubMed]
66. Zhu, S.P.; Liu, G.; Wu, X.T.; Chen, F.X.; Liu, J.Q.; Zhou, Z.H.; Zhang, J.F.; Fei, S.J. The effect of phloretin on human gammadelta T cells killing colon cancer SW-1116 cells. Int. Immunopharmacol. 2013, 15, 6–14. [CrossRef] [PubMed]
67. Yang, W.; Ma, J.; Zhou, W.; Zhou, X.; Cao, B.; Zhang, H.; Zhao, Q.; Fan, D.; Hong, L. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Rev. Gastroenterol. Hepatol. 2017, 11, 1151–1163. [CrossRef]
68. Goldstein, L.J. Clinical reversal of drug resistance. Curr. Probl. Cancer 1995, 19, 65–124. [CrossRef]
69. Bai, X.; Chen, Y.; Hou, X.; Huang, M.; Jin, J. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters. Drug Metab. Rev. 2016, 48, 541–567. [CrossRef]
70. Xue, X.; Liang, X.J. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology. Chin. J. Cancer 2012, 31, 100–109. [CrossRef]
71. Nguyen, H.; Zhang, S.; Morris, M.E. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J. Pharm. Sci. 2003, 92, 250–257. [CrossRef] [PubMed]
72. Molnar, J.; Engi, H.; Hohmann, J.; Molnar, P.; Deli, J.; Wesolowska, O.; Michalak, K.; Wang, Q. Reversal of multidrug resitance by natural substances from plants. Curr. Top. Med. Chem. 2010, 10, 1757–1768. [PubMed]
73. Choi, B.M.; Chen, X.Y.; Gao, S.S.; Zhu, R.; Kim, B.R. Anti-apoptotic effect of phloretin on cisplatin-induced apoptosis in HEI-OC1 auditory cells. Pharmacol. Rep. 2011, 63, 708–716. [CrossRef]
74. Zhou, M.; Zheng, J.; Bi, J.; Wu, X.; Lyu, J.; Gao, K. Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin. Oncol. Lett. 2018, 15, 1985–1992. [CrossRef]
75. Adam, A.; Crespy, V.; Levrat-Verny, M.A.; Leenhardt, F.; Leuillet, M.; Demigne, C.; Remesy, C. The bioavailability of ferulic acid is governed primarily by the food matrix rather than its metabolism in intestine and liver in rats. J. Nutr. 2002, 132, 1962–1968. [CrossRef] [PubMed]
76. Kahle, K.; Kraus, M.; Scheppach, W.; Richling, E. Colonic availability of apple polyphenols–a study in ileostomy subjects. Mol. Nutr. Food Res. 2005, 49, 1143–1150. [CrossRef] [PubMed]
77. Deusser, H.; Rogoll, D.; Scheppach, W.; Volk, A.; Melcher, R.; Richling, E. Gastrointestinal absorption and metabolism of apple polyphenols ex vivo by the pig intestinal mucosa in the Ussing chamber. Biotechnol. J. 2013, 8, 363–370. [CrossRef]
78. Geohagen, B.C.; Korsharskyy, B.; Vydyanatha, A.; Nordstroem, L.; LoPachin, R.M. Phloretin cytoprotection and toxicity. Chem. Biol. Interact. 2018, 296, 117–123. [CrossRef]